Callan JMB Inc

Callan JMB Inc(CJMB)股票分析

$0.574

+0.058 (+10.17%)收盤時

Loading chart…
最高
0.635
開盤
0.569
成交量加權均價
0.59
成交量
27.56M
市值
—
最低
0.546
成交金額
16.13M
企業價值/稅息折舊攤銷前利潤(TTM)
0.00

Callan JMB Inc. is a vertically integrated logistics and fulfillment company, which provides thermal management logistics solutions to the life sciences industry through a combination of proprietary packaging, information technology and specialized cold chain logistics knowhow. The Company provides comprehensive alternatives to all logistics solutions and services utilized for frozen shipping in the life sciences industry (personalized medicine, cell therapies, stem cells, cell lines, vaccines, diagnostic materials, semen, eggs, embryos, cord blood, organs, biopharmaceuticals, infectious substances, and other commodities that require continuous exposure to cryogenic or frozen temperatures). Its Ship2Q ultraviolet disinfection process (Safe Hygienic Irradiation Performance Process & Qualification) ensures fitness, thermal reliability, and cleanliness of the system components within the manufacturers specifications equal to new off-the-shelf shipper systems.

AI 分析 of Callan JMB Inc (CJMB)

賣出

Callan JMB Inc. is not a good buy right now due to significant financial losses and declining revenue. The current price is $0.57, with a staggering 1-year change of -85.83%, indicating a severe drop in value. Additionally, the company reported a net income loss of -$3,215,054 in Q1 2026, which raises concerns about its financial viability.

估值指標

Callan JMB Inc(CJMB)目前預期本益比為 0.00,5 年平均預期本益比為 0.00。

預期本益比

嚴重低估
5 年均值 P/E
0.00
目前P/E
0.00
高估
0.00
低估
0.00

預期 EV/EBITDA

嚴重低估
5 年均值 EV/EBITDA
0.00
目前EV/EBITDA
0.00
高估
0.00
低估
0.00

預期股價營收比

嚴重低估
5 年均值 P/S
0.00
目前P/S
0.00
高估
0.00
低估
0.00

Alphio AI 對 CJMB 的價格情境

情境價格取自當年最後一個月度預測區間。機率為固定的模型權重(25 / 50 / 25),不構成保證。

樂

樂觀

樂觀 · 25%CJMB

$7.05

情境價格

基

基準

基準 · 50%CJMB

$6.02

情境價格

悲

悲觀

悲觀 · 25%CJMB

$5.29

情境價格

事件時間軸

2026-10-22 (ET)

08:30:00

Callan JMB Invests $16M to Build IV Bag Facility in Alabama

2026-08-11 (ET)

08:30:00

Callan JMB and Alabama State University Form Strategic Joint Venture with $60M Investment

2026-07-16 (ET)

09:30:00

Callan JMB Forms Strategic Partnership with Alabama State University

2026-07-08 (ET)

17:30:00

Callan JMB Forms Strategic Partnership with Alabama State University

2026-05-20 (ET)

09:10:00

Callan JMB Expands Public Sector Contract Worth Approximately $1.05M

資訊

CJMB 常見問題 —— 由 Alphio AI 解答

Callan JMB Inc. is a vertically integrated logistics and fulfillment company, which provides thermal management logistics solutions to the life sciences industry through a combination of proprietary packaging, information technology and specialized cold chain logistics knowhow. The Company provides comprehensive alternatives to all logistics solutions and services utilized for frozen shipping in the life sciences industry (personalized medicine, cell therapies, stem cells, cell lines, vaccines, diagnostic materials, semen, eggs, embryos, cord blood, organs, biopharmaceuticals, infectious substances, and other commodities that require continuous exposure to cryogenic or frozen temperatures). Its Ship2Q ultraviolet disinfection process (Safe Hygienic Irradiation Performance Process & Qualification) ensures fitness, thermal reliability, and cleanliness of the system components within the manufacturers specifications equal to new off-the-shelf shipper systems. It operates in the Industrials sector.

Callan JMB Inc. is not a good buy right now due to significant financial losses and declining revenue. The current price is $0.57, with a staggering 1-year change of -85.83%, indicating a severe drop in value. Additionally, the company reported a net income loss of -$3,215,054 in Q1 2026, which raises concerns about its financial viability.

暫無貼文

註冊或登入後參與討論

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

開始交易